These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30667546)

  • 21. Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice.
    Brzózka MM; Fischer A; Falkai P; Havemann-Reinecke U
    Behav Brain Res; 2011 Apr; 218(2):280-7. PubMed ID: 21070814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
    Abalo R; Cabezos PA; Vera G; Fernández-Pujol R; Martín MI
    Neurogastroenterol Motil; 2010 Jun; 22(6):694-e206. PubMed ID: 20132133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute effects of the cannabinoid receptor agonist WIN55212-2 on dopamine release in rat: an in vivo electrochemical study.
    Wu WC; Wang Y; Chai CY
    Chin J Physiol; 2008 Jun; 51(3):152-9. PubMed ID: 18935910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timing and delay discounting in attention-deficit/hyperactivity disorder: A translational approach.
    Fox AE; Nicholson AM; Singha D; Thieret BAS; Ortiz M; Visser EJ
    Dev Psychobiol; 2023 Jul; 65(5):e22399. PubMed ID: 37338253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impulsive choice behavior in four strains of rats: evaluation of possible models of Attention-Deficit/Hyperactivity Disorder.
    Garcia A; Kirkpatrick K
    Behav Brain Res; 2013 Feb; 238():10-22. PubMed ID: 23085479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bi-directional cannabinoid signalling in the basolateral amygdala controls rewarding and aversive emotional processing via functional regulation of the nucleus accumbens.
    Ahmad T; Sun N; Lyons D; Laviolette SR
    Addict Biol; 2017 Sep; 22(5):1218-1231. PubMed ID: 27230434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of cannabinoid system in the nucleus accumbens on delay-based decision making in the rat.
    Fatahi Z; Sadeghi B; Haghparast A
    Behav Brain Res; 2018 Jan; 337():107-113. PubMed ID: 28987618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneously hypertensive (SHR) rats choose more impulsively than Wistar-Kyoto (WKY) rats on a delay discounting task.
    Aparicio CF; Hennigan PJ; Mulligan LJ; Alonso-Alvarez B
    Behav Brain Res; 2019 May; 364():480-493. PubMed ID: 28963043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression.
    Segev A; Rubin AS; Abush H; Richter-Levin G; Akirav I
    Neuropsychopharmacology; 2014 Mar; 39(4):919-33. PubMed ID: 24141570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of protective effects of non-selective cannabinoid receptor agonist WIN 55,212-2 against the nitroglycerine-induced acute and chronic animal models of migraine: A mechanistic study.
    Mohammadi Vosough E; Baradaran Rahimi V; Masoud SA; Mirkarimi HR; Demneh MK; Abed A; Banafshe HR; Askari VR
    Life Sci; 2019 Sep; 232():116670. PubMed ID: 31330139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala.
    Di S; Itoga CA; Fisher MO; Solomonow J; Roltsch EA; Gilpin NW; Tasker JG
    J Neurosci; 2016 Aug; 36(32):8461-70. PubMed ID: 27511017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylphenidate and Atomoxetine-Responsive Prefrontal Cortical Genetic Overlaps in "Impulsive" SHR/NCrl and Wistar Rats.
    Dela Peña I; Dela Peña IJ; de la Peña JB; Kim HJ; Shin CY; Han DH; Kim BN; Ryu JH; Cheong JH
    Behav Genet; 2017 Sep; 47(5):564-580. PubMed ID: 28744604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caffeine Consumption plus Physical Exercise Improves Behavioral Impairments and Stimulates Neuroplasticity in Spontaneously Hypertensive Rats (SHR): an Animal Model of Attention Deficit Hyperactivity Disorder.
    França AP; Schamne MG; de Souza BS; da Luz Scheffer D; Bernardelli AK; Corrêa T; de Souza Izídio G; Latini A; da Silva-Santos JE; Canas PM; Cunha RA; Prediger RD
    Mol Neurobiol; 2020 Sep; 57(9):3902-3919. PubMed ID: 32621279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
    Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
    Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeine improves spatial learning deficits in an animal model of attention deficit hyperactivity disorder (ADHD) -- the spontaneously hypertensive rat (SHR).
    Prediger RD; Pamplona FA; Fernandes D; Takahashi RN
    Int J Neuropsychopharmacol; 2005 Dec; 8(4):583-94. PubMed ID: 15877934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.
    Scholl A; Ivanov I; Hinz B
    Oncotarget; 2016 Sep; 7(38):61438-61457. PubMed ID: 27556861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2.
    Payandemehr B; Ebrahimi A; Gholizadeh R; Rahimian R; Varastehmoradi B; Gooshe M; Aghaei HN; Mousavizadeh K; Dehpour AR
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():140-5. PubMed ID: 25448777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder.
    Kantak KM; Singh T; Kerstetter KA; Dembro KA; Mutebi MM; Harvey RC; Deschepper CF; Dwoskin LP
    Behav Neurosci; 2008 Apr; 122(2):340-57. PubMed ID: 18410173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.